GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Healthcare Corp (AMEX:NHC) » Definitions » Peter Lynch Fair Value

National Healthcare (National Healthcare) Peter Lynch Fair Value : N/A (As of Apr. 25, 2024)


View and export this data going back to 1987. Start your Free Trial

What is National Healthcare Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for National Healthcare's Peter Lynch Fair Value or its related term are showing as below:


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of National Healthcare was 3.06. The lowest was 3.06. And the median was 3.06.


NHC's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.345
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


National Healthcare Peter Lynch Fair Value Historical Data

The historical data trend for National Healthcare's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Healthcare Peter Lynch Fair Value Chart

National Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 22.22 - -

National Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of National Healthcare's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, National Healthcare's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Healthcare's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where National Healthcare's Price-to-Peter-Lynch-Fair-Value falls into.



National Healthcare Peter Lynch Fair Value Calculation

National Healthcare's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *3.57
=N/A

National Healthcare's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.57.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


National Healthcare  (AMEX:NHC) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

National Healthcare's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=91.09/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Healthcare Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of National Healthcare's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


National Healthcare (National Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
100 East Vine Street, Murfreesboro, TN, USA, 37130
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
Executives
Emil E Hassan director
Robert G Adams director, officer: Sr. Vice President & COO P.O. BOX 1398, MURFREESBORO TN 37133-1398
James Paul Abernathy director 2102 GREENLAND DRIVE, MURFREESBORO TN 37130
W Andrew Adams director, officer: CEO P.O. BOX 1398, MURFREESBORO TN 37133-1398
Laroche Richard F Jr director P.O. BOX 1398, MURFREESBORO TN 37133-1398
Burgess Ernest G Iii director P.O. BOX 1398, MURFREESBORO TN 37133-1398
Sandra Y. Trail director 100 VINE STREET, MURFREESBORO TN 37130
Robert Michael Ussery officer: Senior V.P., Operations 100 VINE STREET, SUITE 1400, P. O. BOX 1398, MURFREESBORO TN 37130
Vicki L Dodson officer: Sr.VP Patient Srvcs & CNO 100 VINE STREET, MURFREESBORO TN 37130
Josh A Mccreary officer: Senior VP & General Counsel 100 VINE STREET, MURFREESBORO TN 37130
John K Lines officer: Senior V.P. & General Counsel 601 S. HARBOUR ISLAND BLVD., SUITE 220, TAMPA FL 33602
Jeffrey Russell Smith officer: SVP & Treasurer 100 VINE ST., MURFREESBORO TN 37130
Mcintosh Leroy E. Jr. officer: SVP, Ancillary Services 100 VINE STREET, MURFREESBORO TN 37130
Julia W Powell officer: Sr. V.P., Patient Services 3712 LASCASSAS PIKE, MURFREESBORO TN 37130
Flatt Ben Anderson Sr officer: Senior VP & CIO 100 VINE STREET, MURFREESBORO TN 37130